-
EP0661972
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0661972
| EP0661972 - USE OF SPIPERONE OR SPIPERONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.11.1999 Database last updated on 26.06.2024 | Most recent event Tooltip | 05.11.1999 | Application deemed to be withdrawn | published on 22.12.1999 [1999/51] | Applicant(s) | For all designated states BETH ISRAEL HOSPITAL 330 Brookline Avenue Boston Massachusetts 02215 / US | [N/P] |
| Former [1995/28] | For all designated states BETH ISRAEL HOSPITAL 330 Brookline Avenue Boston Massachusetts 02215 / US | Inventor(s) | 01 /
SHARPE, Richard, J. 30 Melbourne Avenue Newtonville, MA 02160 / US | 02 /
ARNDT, Kenneth, A. 104 Lake Avenue Newton Centre, MA 02159 / US | 03 /
GALLI, Stephen, J. 9 Lakeview Terrace Winchester, MA 01890 / US | 04 /
MELTZER, Peter, C. 8 Rumford Road Lexington, MA 02173 / US | 05 /
RAZDAN, Raj, K. 76 Lawrence Lane Belmont, MA 02178 / US | 06 /
SARD, Howard, P. 67 Hillside Avenue Arlington, MA 02174 / US | [1995/28] | Representative(s) | Bassett, Richard Simon, et al Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
| Former [1995/28] | Bassett, Richard Simon, et al ERIC POTTER & CLARKSON St. Mary's Court St. Mary's Gate Nottingham NG1 1LE / GB | Application number, filing date | 93902752.0 | 23.12.1992 | [1995/28] | WO1992US11205 | Priority number, date | US19910815283 | 27.12.1991 Original published format: US 815283 | US19920831429 | 05.02.1992 Original published format: US 831429 | US19920893536 | 04.06.1992 Original published format: US 893536 | US19920893534 | 04.06.1992 Original published format: US 893534 | [1995/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9312789 | Date: | 08.07.1993 | Language: | EN | [1993/16] | Type: | A1 Application with search report | No.: | EP0661972 | Date: | 12.07.1995 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.07.1993 takes the place of the publication of the European patent application. | [1995/28] | Search report(s) | International search report - published on: | US | 08.07.1993 | (Supplementary) European search report - dispatched on: | EP | 27.10.1994 | Classification | IPC: | A61K31/44, A61K31/435 | [1995/28] | CPC: |
A61K31/435 (EP);
A61P37/06 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1995/28] | Title | German: | VERWENDUNG VON SPIPERON UND SPIPERONDERIVATEN ALS IMMUNSUPPRESSIVE WIRKSTOFFE | [1995/28] | English: | USE OF SPIPERONE OR SPIPERONE DERIVATIVES AS IMMUNOSUPPRESSANT AGENTS | [1995/28] | French: | UTILISATION DE LA SPIPERONE OU DE DERIVES DE LA SPIPERONE COMME AGENTS IMMUNODEPRESSEURS | [1995/28] | Entry into regional phase | 27.07.1994 | National basic fee paid | 27.07.1994 | Search fee paid | 27.07.1994 | Designation fee(s) paid | 27.07.1994 | Examination fee paid | Examination procedure | 26.07.1993 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 27.07.1994 | Examination requested [1995/28] | 16.04.1998 | Despatch of a communication from the examining division (Time limit: M06) | 22.10.1998 | Reply to a communication from the examining division | 01.07.1999 | Application deemed to be withdrawn, date of legal effect [1999/51] | 29.07.1999 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [1999/51] | Fees paid | Renewal fee | 22.12.1994 | Renewal fee patent year 03 | 29.03.1996 | Renewal fee patent year 04 | 11.12.1996 | Renewal fee patent year 05 | 12.12.1997 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.12.1995 | 04 M06 Fee paid on 29.03.1996 | 31.12.1998 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]WO9113622 (BETH ISRAEL HOSPITAL [US]) [X] 1-17,19-28 * the whole document * [A] 18,29; | [X]WO9102527 (BETH ISRAEL HOSPITAL [US]) [X] 1-4,8-10,13,14,16,21-23,26 * abstract * * page 10, line 1 - page 11, line 20 * * page 18, line 30 - page 19, line 28; examples 2-4; claims 1-5,8-14,16-20 * | [T] - A. CHANDRASEKAR ET AL., "SPIPERONE METHYL AMMONIUM BROMIDE INHIBITS CUTANEOUS CONTACT HYPERSENSITIVITY IN THE MOUSE", CLINICAL RESEARCH, (1993), vol. 41, no. 3, page 606A [T] 1-29 * the whole document * | [PX] - R.J. SHARPE ET AL., "INHIBITION OF CUTANEOUS CONTACT HYPERSENSITIVITY IN THE MOUSE WITH SYSTEMIC OR TOPICAL SPIPERONE: TOPICAL APPLICATION OF SPIPERONE PRODUCES LOCAL IMMUNOSUPPRESSION WITHOUT INDUCING SYSTEMIC NEUROLEPTIC EFFECTS", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, (199211), vol. 99, no. 5, pages 594 - 600 [PX] 1-4,8-10,13,14,16,22,23,28 * the whole document * | [A] - E. OKKERSE ET AL., "IDENTIFICATION OF CRYSTALLINE DERIVATIVES OF BUTYROPHENONES BY X-RAY DIFFRACTION: ...", JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS, (1971), vol. 54, no. 6, pages 1406 - 1419 [A] 5-7,18,29 * the whole document * | [DA] - S.M. MOERLEIN ET AL., "EFFECT OF LIPOPHILICITY ON THE IN VIVO LOCALIZATION OF RADIOLABELLED SPIPERONE ANALOGUES", INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE AND BIOLOGY, (1985), vol. 12, no. 5, pages 353 - 356 [DA] 1-29 * the whole document * | International search | [X]US3155669 ; | [X]US4839342 |